查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球神经血管导管市场
市场调查报告书
商品编码
1140765

2022-2029 年全球神经血管导管市场

Global Neurovascular Catheters Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

预计神经血管导管的市场规模在预测期间（2022-2029 年）将以 6.7% 的复合年增长率增长。

神经血管导管用于从神经血管器官（例如大脑、颅腔和颈动脉）排出或抽取不需要的液体。我们还向神经血管器官给药并诊断神经血管疾病，例如动脉瘤和颈动脉疾病。

市场动态

由于神经血管疾病的流行、研发投资和技术进步，全球神经血管导管市场正在增长。

神经血管疾病的日益流行和技术进步正在推动全球市场的增长。

缺血性中风、狭窄和脑动脉瘤等神经血管疾病病例不断增加，预计将推动市场增长。例如，根据世界卫生组织的数据，三分之一的人会在他们生命的某个阶段患上神经系统疾病。过去 30 年来，神经系统疾病导致的死亡人数增加了近 40%。根据世界中风组织 (WSO) 的数据，中风仍然是导致死亡的第二大原因，也是导致死亡和残疾的第三大原因。在全球范围内，70% 的中风和 87% 的中风相关死亡和残疾调整生命年发生在低收入和中等收入国家。全世界每年约有 1500 万人中风。其中，500 万人死亡，另外 500 万人永久残疾。因此，越来越多的缺血性中风患者正在推动市场。

并发症和熟练专业人员的短缺正在阻碍全球神经血管导管市场的增长。

与神经血管导管相关的并发症预计将抑制市场。在血管中放置导管的过程存在一定的风险。这些包括受损的血管、穿刺部位出血和感染。 FDA 表示，它已收到少量不良事件报告，表明患者受伤和至少一名死亡与以这种方式使用的神经血管引导导管有关。此外，在血栓切除术中使用神经血管引导导管对安全性和性能有影响，并且在微血管最远端区域使用时会产生严重的并发症，如装置故障和穿孔、血管损伤和夹层等，可能会产生严重的副作用。

行业分析

《全球神经血管导管市场报告》根据波特五力、创新、新产品发布、定价和流行病学分析等各种行业因素对市场进行了深入分析。

细分分析

预计微导管细分市场在预测期间（2022-2029 年）将有很高的需求。

由于微导管的进步，预计微导管细分市场将在预测期内快速增长。例如，Covidien plc 的 Apollo Onyx 输送微导管是美国第一款可拆卸尖端微导管。这种新型微导管旨在解决 Onyx LES 栓塞动静脉畸形 (bAVM) 中导管取出的技术挑战。此外，Vascular Perspective Co., Ltd. 的锥形尖端微导管“ASAHI CORSAIR PRO”改善了跟随性和扭矩传递，降低了并发症的可能性，取得了更好的治疗效果。此外，基于连接到微流体系统的自组装聚合物薄膜的电子集成微导管的开发允许以有针对性的方式填充和密封血管缺陷，例如动脉瘤。现在可以输送液体有效载荷。在预测期内（2022-2029 年），微导管领域的这些进步增加了其在全球市场的主导地位。

区域分析

预计全球神经血管导管市场将由北美主导。

北美将在 2021 年主导全球神经血管导管市场。由于神经血管疾病病例数量的增加和市场上最大的导管回收器，预计在预测期内（2022-2029 年）将保持可观的市场规模。例如，根据 CDC 的数据，2019 年大约有 223,135 例 TBI 相关住院，2020 年有 64,362 例 TBI 相关死亡，每天有 611 例 TBI 相关住院和 176 例死亡。来自 CDC 的数据不包括在急诊科、初级保健、紧急护理和未经治疗的 TBI 治疗，许多 TBI 患者仍然存在。据脑动脉瘤基金会称，美国约有 650 万人患有未破裂的脑动脉瘤。每年每 100,000 人中约有 8 到 10 人破裂。在美国，每年约有 30,000 人患有脑动脉瘤破裂。脑动脉瘤每 18 分钟破裂一次。此外，Stryker Corporation、Johnson and Johnson、Penumbra Inc. 和 Medtronic Plc 是美国主要的市场参与者，它们确保了北美在全球市场的主导地位并占据了大部分市场份额。

竞争格局

全球神经血管导管市场的主要参与者有 Stryker、Medtronic、Integer Holdings Corporation、DePuy Synthes（强生公司）、Biomerics、Zeus Industrial Products, Inc.、Imperative Care Inc 和 Penumbra, Inc.。主要参与者采取了各种策略，如产品发布、併购、合作伙伴和联盟，为全球神经血管导管市场的增长做出贡献。例如，2022 年 7 月 12 日，美敦力宣布与 CathWorks 达成共同推广协议，并宣布计划收购它。此外，2022 年 3 月 1 日，Stryker 收购了 Vocera。

美敦力公司

概述

Medtronic PLC 是一家总部位于爱尔兰的美国医疗设备製造商。美敦力公司成立于 1949 年，总部位于美国明尼苏达州明尼阿波利斯市。美敦力经营四项业务：微创治疗组、糖尿病组、恢復性治疗组和心血管组。

产品组合。

美敦力的神经血管导管产品组合包括 Navien、Phenom、React 抽吸导管、Apollo Onyx 输送微导管、Echelon 微导管等。

全球神经血管导管市场报告将提供对大约 40 多个市场数据表、45 多个数字和 200 多页（大约）的访问。

内容

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 神经血管疾病病例增加
      • 老年人口增加
      • 市场策略
    • 限制因素
      • 缺乏熟练的专业人员
      • 相关并发症
    • 商机
    • 影响分析

第5章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按类型

  • 微导管
  • 气球导管
  • 接入导管
  • 栓塞导管
  • 其他

第 8 章按材料分类

  • 氟化乙烯丙烯
  • 液晶聚合物
  • 尼龙
  • 聚醚嵌段□胺
  • 聚醚醚酮
  • 其他

第 9 章按应用程序

  • 动脉瘤
  • 神经血管栓塞
  • 椎窦瘘
  • 动脉血管痉挛
  • 其他

第 10 章，最终用户

  • 医院
  • 门诊手术中心 (ASC)
  • 其他

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准

第 13 章公司简介

  • 美敦力公司
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Stryker
  • Integer Holdings Corporation
  • DePuy Synthes（Johnson and Johnson）
  • Biomerics
  • Zeus Industrial Products, Inc.
  • Imperative Care Inc.
  • Penumbra, Inc.

第14章 DataM

简介目录
Product Code: DMMD2103

Market Overview

Neurovascular Catheters Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 6.7% during the forecast period (2022-2029).

A neurovascular catheter is used to drain or withdraw unwanted fluid from neurovascular organs such as the brain, intracranial spaces, carotid artery, etc. It also administers medications to the neurovascular organs and diagnoses several neurovascular diseases like aneurysms, carotid artery disease, etc.

Market Dynamics

The global neurovascular catheter market is growing due to the prevalence of neurovascular disorders, R&D investments, and technological advancements.

The increasing prevalence of neurovascular disorders and technological advancements propel global market growth.

The increasing cases of neurovascular disorders like ischemic Stroke, stenosis, brain aneurysm, and other illnesses are expected to boost the market. For instance, according to WHO, 1 in 3 people are affected by a neurological disease at some point in their life. Over the past 30 years, the number of deaths due to neurological disorders has increased by almost 40%. As per the World Stroke Organization (WSO), Stroke remains the second-leading cause of death and the third-leading cause of death and disability combined. Also, globally, 70% of strokes and 87% of stroke-related deaths and disability-adjusted life years occur in low- and middle-income countries. Around 15 million people suffer from Stroke worldwide each year. Of these, 5 million die, and another 5 million are permanently disabled. Thus, the increasing number of ischemic stroke cases is driving the market.

The complications and lack of skilled professionals hinder the global neurovascular catheter market growth.

The complications associated with neurovascular catheters are expected to restrain the market. Any procedure that places a catheter inside a blood vessel carries certain risks. They include damage to the blood vessel, bleeding at the puncture site, and infection. FDA stated that it had received a small number of adverse event reports indicating patient injury, and at least one death, associated with the neurovascular guide catheters used in this manner. Also, the use of neurovascular guide catheters for thrombus removal may affect safety and performance, resulting in device failure and other serious adverse effects like perforation, vessel damage, or dissection when used in the most distal regions of the microvasculature.

Industry analysis.

The global neurovascular catheters market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, epidemiological analysis, Etc.

Segment Analysis

The microcatheter segment is predicted to have a high demand during the forecast period (2022-2029).

The microcatheter segment is expected to grow rapidly over the forecast period, owing to microcatheter advancements. For instance, Covidien plc's Apollo Onyx delivery microcatheter is the first detachable tip microcatheter available in the US. The new microcatheter is designed to solve catheter retrieval's technical challenges during Onyx LES embolizations of arteriovenous brain malformations (bAVMs). Also, ASAHI CORSAIR PRO, a tapered tip microcatheter by Vascular Perspectives Ltd., has increased trackability and torque transmission giving better outcomes with a low probability of complications. Furthermore, the development of Electronically integrated microcatheters based on self-assembling polymer films connected to a microfluidic system allows to deliver of a liquid payload in a targeted manner, e.g., to fill and seal a blood vessel defect, e.g., an aneurysm. These advancements in the microcatheter segment are fueling its dominance over the global market during the forecast period (2022-2029).

Geographical Analysis

North America is predicted to command the global neurovascular catheter market.

North America dominated the global neurovascular catheter market in 2021. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to the increasing cases of neurovascular disorders and maximum catheter retrievers in the market. For instance, as per CDC, in 2019, there were around 223,135 TBI-related hospitalizations and 64,362 deaths in 2020 claimed by TBI, making up 611 hospitalizations and 176 deaths daily as TBI the cause. This data from the CDC excludes the TBI treated in emergency departments, primary care, urgent care or untreated ones leaving behind many TBI patients. According to the Brain Aneurysm Foundation, around 6.5 million United States people have an unruptured brain aneurysm. Annually approximately 8 - 10 per 100,000 people rapture occurs. About 30,000 people in the United States suffer a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. Furthermore, Stryker Corporation, Johnson and Johnson, Penumbra Inc. and Medtronic Plc are the United States-based key market players holding most of the market share, ensuring the dominance of North America over the global market.

Competitive Landscape

The major global neurovascular catheter market players are Stryker, Medtronic, Integer Holdings Corporation, DePuy Synthes (Johnson and Johnson), Biomerics, Zeus Industrial Products, Inc, Imperative Care Inc, and Penumbra, Inc. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the neurovascular catheters market globally. For instance, on July 12, 2022, Medtronic announced a co-promotion agreement with CathWorks, with an acquisition plan. Also, on 01-Mar-2022, Stryker acquired Vocera.

Medtronic, Plc.

Overview:

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio:

The Medtronic, Plc product portfolio for neurovascular catheters contains Navien, Phenom, React Aspiration Catheters, Apollo Onyx delivery microcatheter, Echelon microcatheter, Etc.

The global neurovascular catheters market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing Cases of Neurovascular Disorders
      • 4.1.1.2. Growing Geriatric Population
      • 4.1.1.3. Market Strategies
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Skilled Professional
      • 4.1.2.2. Associated Complication
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Microcatheter
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Balloon catheter
  • 7.4. Access catheters
  • 7.5. Embolization catheters
  • 7.6. Others

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Segment
    • 8.1.2. Market Attractiveness Index, By Material Segment
  • 8.2. Fluorinated Ethylene Propylene
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Liquid Crystal Polymer
  • 8.4. Nylon
  • 8.5. Polyether Block Amide
  • 8.6. Polyether Ether Ketone
  • 8.7. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Aneurysms
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Neurovascular Embolic Stroke
  • 9.4. Vertebral And Sinus Fistulas
  • 9.5. Arterial Vasospasm
  • 9.6. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers (ASCs)
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Medtronic, Plc
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Stryker
  • 13.3. Integer Holdings Corporation
  • 13.4. DePuy Synthes (Johnson and Johnson)
  • 13.5. Biomerics
  • 13.6. Zeus Industrial Products, Inc.
  • 13.7. Imperative Care Inc.
  • 13.8. Penumbra, Inc.

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us